5:56 PM
 | 
May 15, 2013
 |  BC Extra  |  Financial News

Acadia raises $100 million in follow-on

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) raised $100 million through the sale of 8 million shares at $12.50 in a follow-on underwritten by Jefferies; Cowen; JMP Securities; Needham; Ladenburg Thalmann; Roth...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >